Primary Care Clinic in Sherman TX | Highland Primary Care
It's a hormone problem.
GLP-1 medications restore the biological signals that control hunger. Weekly nurse-administered injections. Office visits billed to insurance. Real physician oversight — not a shipping box.
*Based on clinical trial data for semaglutide and tirzepatide. Individual results vary. Supervised by Shahram Sani, MD · Texas Medical Board Licensed.
The Science
Decades of dieting, calorie restriction, and willpower battles don't fail because you lack discipline. They fail because they don't address the underlying biology. Obesity is a chronic hormonal condition. It requires a medical solution.
"GLP-1 medications are the most significant advance in obesity medicine in a generation. They address the root cause — not just the symptoms."
GLP-1 and GIP signaling are blunted in people with obesity, causing persistent hunger even when caloric needs are met. No amount of willpower overrides a broken hormonal signal.
These medications act on the same receptors your body uses to sense fullness after eating — dramatically reducing hunger, slowing gastric emptying, and improving insulin sensitivity.
In randomized controlled trials, participants lost an average of 15–22% of total body weight over 68–72 weeks. This is 3–4× more than any previous medication class. Individual results vary.
The Process
One-time in-person visit with Dr. Sani. We review your health history, medications, and weight loss goals. Baseline labs ordered through insurance. $99 one-time fee.
Dr. Sani prescribes your starting dose from a licensed Texas 503A compounding pharmacy. We handle all paperwork and insurance verification for visit billing.
Every week, you come in for a nurse-administered injection. No syringes at home, no guesswork. Your nurse tracks progress and manages side effects.
Monthly provider visits (billed to insurance) for dose adjustments, lab review, and optimization. Real medical management — not a pill-mill.
Why Choose Us
Telehealth weight loss companies mail you medication and leave you alone. We're a local medical practice — we see you weekly, bill your insurance, and actually manage your care.
Highland Primary Care
Telehealth (Ro, Hims, Noom Med)
Plans & Pricing
Monthly medication cost shown. Insurance may cover office visits and labs separately.
Semaglutide
Starter
0.25 – 0.5 mg/week
4 weekly injections included
Semaglutide
Therapeutic
1.0 – 2.4 mg/week
4 weekly injections included
Most Effective
Tirzepatide
Starter
2.5 – 5 mg/week
4 weekly injections included
Tirzepatide
Therapeutic
7.5 – 15 mg/week
$249/mo at 10mg+ doses
New patient consultation: $99 one-time fee. Includes in-person exam with Dr. Sani, MD, medical history review, and treatment plan. Required before starting any plan. Call (903) 871-5671 or visit 300 N Highland Ave, Suite 455, Sherman, TX.
Highland Primary Care has served the Sherman community for years. This program was designed because we kept watching patients struggle with telehealth companies — getting medication shipped, getting no follow-up, and getting no results.
Weekly in-person visits mean we catch side effects early, adjust doses appropriately, and hold you accountable in a way no app ever can. This is primary care medicine applied to a condition that has always deserved better.
Shahram Sani, MD
Board-Certified Internal Medicine · Medical Director, Highland Primary Care
Texas Medical Board Licensed · 300 N Highland Ave, Suite 455, Sherman, TX 75092
Questions & Answers
We use compounded semaglutide and tirzepatide from a licensed Texas 503A pharmacy. Tirzepatide remains on the FDA shortage list (April 2026). Dr. Sani documents clinical justification on all prescriptions. These are not the same as brand-name Ozempic or Mounjaro.
In-person visits allow monitoring of side effects, response assessment, and dose adjustment. Texas law requires the initial exam in person. Weekly visits also dramatically improve adherence.
No. Compounded GLP-1 medications are cash-pay. Your monthly plan fee covers medication in full. We bill insurance separately for office visits, provider exams, and labs.
Clinical trials show 15–22% total body weight loss on average over 68–72 weeks. Individual results vary based on adherence, diet, activity, and metabolic factors.
Most common: nausea, constipation, reduced appetite (expected), and injection site reactions. These are typically dose-dependent and improve with slow titration.
GLP-1 medications significantly reduce hunger, making dietary adherence far easier. We provide guidance but don't mandate a specific protocol.
In many cases yes — GLP-1s provide additional metabolic benefits for diabetic patients. Dr. Sani reviews your full medical history at the initial consultation.
We develop a maintenance plan. Most patients require ongoing low-dose therapy. Discontinuing abruptly typically results in weight regain — we plan for the long game.